EGM
VBIV

Engineers Gate Manager’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Engineers Gate Manager’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-443
Closed -$4.02K – 2101
2023
Q1 		$4.02K Hold
443
– – ﹤0.01% 1602
2022
Q4 		$5.19K Buy
443
+8
+2% +$141 ﹤0.01% 1637
2022
Q3 		$9K Sell
435
-55
-11% -$1.48K ﹤0.01% 1551
2022
Q2 		$12K Sell
490
-40
-8% -$1.36K ﹤0.01% 1841
2022
Q1 		$26K Buy
+530
New +$26.2K ﹤0.01% 1776
2021
Q3 		– Sell
-462
Closed -$46K – 2051
2021
Q2 		$46K Buy
+462
New +$45K ﹤0.01% 1548

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return